about
Characterization of oligosaccharides from the chondroitin/dermatan sulfates. 1H-NMR and 13C-NMR studies of reduced trisaccharides and hexasaccharidesIdentification of oligomeric domains within dermatan sulfate chains using differential enzymic treatments, derivatization with 2-aminoacridone and capillary electrophoresis.Tumour necrosis factor-alpha interacts with biglycan and decorin.Metabolism and biochemical/physiological roles of chondroitin sulfates: analysis of endogenous and supplemental chondroitin sulfates in blood circulation.Suppression of amyloid beta A11 antibody immunoreactivity by vitamin C: possible role of heparan sulfate oligosaccharides derived from glypican-1 by ascorbate-induced, nitric oxide (NO)-catalyzed degradation.Accumulation of a pentasaccharide terminating in alpha-N-acetylglucosamine in an animal cell mutant defective in heparan sulfate biosynthesis.Binding of heparan sulfate to Staphylococcus aureus.Biosynthesis of the proteoglycan decorin -- identification of intermediates in galactosaminoglycan assembly.Sequence analysis of heparan sulphate indicates defined location of N-sulphated glucosamine and iduronate 2-sulphate residues proximal to the protein-linkage region.Protective role for proteoglycans against cationic lipid cytotoxicity allowing optimal transfection efficiency in vitro.Domain structure of endothelial heparan sulphate.Sequencing of glycosaminoglycans with potential to interrogate sequence-specific interactions.A tandem mass spectrometric approach to determination of chondroitin/dermatan sulfate oligosaccharide glycoforms.Proteoglycan-mediated inhibition of A beta proteolysis. A potential cause of senile plaque accumulation.Analysis of glycosaminoglycan chains from different proteoglycan populations in human embryonic skin fibroblasts.
P2860
Q28285582-C5AA5712-1E8D-4E7D-81FB-8306C46F5E8EQ30664580-5C567E82-AF07-4CCC-B13C-BFAB0A27F598Q30864778-CFE6A8D5-BC55-4461-A215-C4EBFA8757FFQ33247019-E8E77F84-5F47-415E-A8C7-7B96EEBF7168Q35144959-95B56559-8255-45B0-B740-7D391581B05EQ38295101-630309A0-0A69-4D9B-97D7-F04C73869781Q40148832-D6D5439A-162A-45F7-923A-36666AF4BEC5Q41085488-85FB8E64-36CB-4FDB-AF17-DAC0C3EE6863Q41777711-6E1A8C74-73C8-43FC-A7F5-15683F5B4274Q42043289-F129F380-8D6A-4A0B-B496-1E8E74DC681FQ42862736-9042E430-4A2A-4194-8CF2-1926471D71F0Q43113402-D700E6C4-1FDE-4C5A-BDF0-A37D761B6057Q43247439-153FDB09-AB93-40DB-95CD-1FACC4138C1DQ53201071-52D368B2-A781-476B-9142-062B39C6B29DQ54262286-3ED870E6-8946-4197-9A5B-8F6989582E4A
P2860
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
A method for the sequence analysis of dermatan sulphate
@en
A method for the sequence analysis of dermatan sulphate
@nl
type
label
A method for the sequence analysis of dermatan sulphate
@en
A method for the sequence analysis of dermatan sulphate
@nl
prefLabel
A method for the sequence analysis of dermatan sulphate
@en
A method for the sequence analysis of dermatan sulphate
@nl
P2093
P2860
P356
P1433
P1476
A method for the sequence analysis of dermatan sulphate
@en
P2093
Fransson LA
Havsmark B
Silverberg I
P2860
P304
P356
10.1042/BJ2690381
P407
P577
1990-07-01T00:00:00Z